Evaluation of the effects of rice bran oil administration on metabolic syndrome components, inflammatory condition and Apo A1 to Apo B100 ratio in adult patients with metabolic syndrome

Phase 2

Recruiting

Conditions: Metabolic syndrome.
Metabolic syndrome
E88.81

Registration Number: IRCT20180205038626N10

Lead Sponsor: Rasht University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 50

Inclusion Criteria

Patients with an age range of 20 to 70 years
Patients with metabolic syndrome
Do not use vitamin and mineral supplements, antioxidants, fiber supplements, omega 3
No history of kidney disease, kidney stones, gastrointestinal diseases, gallstones, and autoimmune diseases
No current consumption of alcohol

Exclusion Criteria

Changes in the patient's treatment plan during the study
Changing the type of effective drugs used factors studied
Reluctance to continue the study or to cause any dissatisfaction with the taste of the oil or to participate in the study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum lipid profile levels (triglycerides, total cholesterol, LDL-C and HDL-C). Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: BT2000 devices.;Serum levels of Apo A1 and Apo B100. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: Nefrometric devices.;Fasting blood sugar. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: BT2000 devices.;CRP. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: ELISA Devices.;D-dimer. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: ELISA Device.

Secondary Outcome Measures

Name	Time	Method
Mean systolic blood pressure. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: Pressure indicator.;Mass Index body. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: Centimeter and scales.;Waist. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: Centimeter.;Mean diastolic blood pressure. Timepoint: At the beginning of the study and 8 weeks later. Method of measurement: Pressure indicator.